May 16, 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in...
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that PRISTIQ(TM) (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat adult patients with major depressive disorder (MDD), is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily. The Company begins full-scale selling and educational efforts regarding PRISTIQ for physicians this week.
Comments
|
has anyone had success on this?
|
|
|
Hopefully better effects than with cymbalta and the stuff that should be ILLEGAL...effexor
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Treatment For Bipolar Still Complex (from Oct '07) | 8 min | Gail Perry | 312 |
| I will kill myself | 39 min | QT-pie | 31 |
| Bipolar disorder also afflicts children, study ... | 3 hr | Zoompad | 2 |
| i want to die i want to die i want to die | 5 hr | it always co... | 218 |
| Plea for suicide alert on anti-depressants (from Jul '07) | 12 hr | Mama to a 1 ... | 42 |
| Anti-depression drugs don't work - study (from Feb '08) | 12 hr | Zoompad | 15 |
| Accutane Side Effects Exposed: Side Effects of ... (from Feb '07) | Sun | Jack | 1816 |
